Previous work from our team demonstrated that GR could be methylated by the arginine methyltransferase PRMT5 in the nucleus of BC cells (Poulard et al, 2020), suggesting that PRMT5 could be a coregulator of GR. The gene discussed is NR3C1; the disease is breast cancer.